Antibodies to the Epstein-Barr virus transactivator protein (ZEBRA) as a valuable biomarker in young patients with nasopharyngeal carcinoma

International Journal of Cancer

Volumn 86, Issue 1, 2000, Pages 71-75

  Dardari, R'kia ^a   Khyatti, Meriem ^a   Benider, Abdellatif ^b   Jouhadi, Hassan ^b   Kahlain, Ahdelouahad ^b   Cochet, Chantal ^c   Mansouri, Aziz ^d   Gueddari, Brahim El ^d   Benslimane, Abdellah ^a   Joab, Irène ^c  

^a Institut Pasteur du Maroc   (Morocco)

^b CHU Averroes   (Morocco)

^c UF de Génétique Moléculaire HÔpital Lariboisière   (France)

^d AVICENNE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; TRANSACTIVATOR PROTEIN; VIRUS PROTEIN;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CANCER DIAGNOSIS; CHILD; EPSTEIN BARR VIRUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; VIRUS LATENCY; VIRUS REPLICATION;

EID: 0034090598     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(20000401)86:1<71::AID-IJC11>3.0.CO;2-1     Document Type: Article

References (23)

1. BENIDER, A., SAHRAOUI, S., ACHARKI, A., SAMLALI, R. and KAHLAIN, A., Carcinomes du nasopharynx chez l'enfant. Analyse de 50 observations. Bull. Cancer (Paris), 82, 155-161 (1995).
2. CAMMOUN, M., VOGT HOENER, G. and MOURALI, N., Les tumeurs du nasopharynx en Tunisie: étude anatomo-clinique de 143 observations. Tunis Med., 49, 131-141 (1971).
3. CHAOUKI, N. and EL GUEDDARI, B., Epidemiological descriptive approach of cancer in Morocco through the activity of the National Institute of Oncology. Bull. Cancer (Paris), 78, 603-609 (1991).
4. DE VATHAIRE, F., SANCHO GARNIER, H., DE THÉ, H., PIEDDELOUP, C., SCHWAAB, G., HO, J.H.C., ELLOUZ, R., MICHEAU, C., CAMMOUN, M., CACHIN, Y. and DE THÉ, G., Prognostic value of EBV markers in the clinical management of nasopharyngeal carcinoma (NPC): a multicenter follow-up study. Int. J. Cancer, 42, 176-181 (1988).
5. EL GUEDDARI, B., EL HAFED, A., BOUIH, A., EL MORCHID, M. and KAHLAIN, A., Cancer of nasopharynx in Morocco: epidemiological approach, IARC Sci. Publ. 63, pp. 513-524, IARC, Lyon (1984).
6. GEOFFRAY, A., VANEL, D., COUANET, D., PIEKARSKI, J.D. and MASSELOT, J.. Apport de la tomodensitométrie (TDM) dans l'étude de 16 épithéliomas indifférenciés de type nasopharyngé du cavum chez l'enfant. J. Radiol., 12, 705-712 (1983).
7. GLASER, R., STRAIN, E.C., TARR, K.L., HOLLIDAY, J.E., DONNERBERG, R.L. and KIECOLT-GLASER, J.K., Changes in Epstein-Barr virus antibody titres associated with aging. Proc. Soc. exp. Biol. Med., 179, 352-355 (1985).
8. GREENE, M.H., FRAUMENI, J.F. and HOOVER, J.R., Nasopharyngeal cancer among young people in the United States: racial variations by cell type. J. nat. Cancer Inst., 58, 1267-1270 (1977).
9. HENLE, G. and HENLE, W., Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int. J. Cancer, 17, 1-7 (1976).
10. HENLE, W., GUERRA, A. and HENLE, G., False negative and prozone reactions in tests for antibodies to Epstein-Barr virus-associated nuclear antigen. Int. J. Cancer, 13, 751-754 (1974a).
11. HENLE, W., HENLE, G. and HORWITZ, C.A., Epstein-Barr virus-specific diagnostic tests in infectious mononucleosis. Hum. Pathol., 5, 551-565 (1974b).
12. HO, J.H.C., An epidemiologic and clinical study of nasopharyngeal carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 4, 183-188 (1978).
13. LANIER, A., HENLE, W., BENDER, T.R., HENLE, G. and TALBOT, M.L., Epstein-Barr virus-specific antibody titres in seven Alaskan natives before and after diagnosis of nasopharyngeal carcinoma. Int. J. Cancer, 26, 133-137 (1980).
14. LEVINE, P.H. and CONNELLY, R.R., Cancer investigation and management, Vol 2, p. 13, J. Wiley, New York (1985).
15. MARECHAL, V., MEYOHAS, M.C., JOAB, I., GAHA, S., GIOT, J.F., SERGEANT, A. and NICOLAS, J.C,. Enzyme-linked immunosorbent assay for antibodies to ZEBRA, an Epstein-Barr trans-activator. Res. Virol., 144, 397-404 (1993).
16. MATHEW, A., CHENG, H.M., SAM, C.K., JOAB, I., PRASAD, U. and COCHET, C., A high incidence of serum IgG antibodies to the Epstein-Barr virus replication activator protein in nasopharyngeal carcinoma. Cancer Immunol. Immunother., 38, 68-70 (1994).
17. SE THOE, S.Y., SAM, C.K., CHENG, H.M. and PRASAD, U., Improved sensitivity of detection by avidin-biotin complex (ABC) immunocytochemistry in Epstein-Barr virus serology. J. med. Virol., 29, 311-314 (1989).
18. SHANMUGARATNAM, K., CHAN, S.H., DE THÉ, G., GOH, J.E., KHOR, T.H., SIMONS, M.J. and TYE, C.Y., Histopathology of nasopharyngeal carcinoma. Correlations with epidemiology, survival rates and other biological characteristics. Cancer, 44, 1029-1044 (1979).
19. SIGEL, G., SCHILLINGER, M., HENNINGER, K. and BAUER, G., IgA directed against early antigen of Epstein-Barr virus is no specific marker for the diagnosis of nasopharyngeal carcinoma. J. med. Virol., 43, 222-227 (1994).
20. VAUR, L., AGUT, H., GARBARG-CHENON, A., PRUD'HOMME DE SAINTMAUR, G., NICOLAS, J.C. and BRICOUT, F., Simplified enzyme-linked immunosorbent assay for specific antibodies to respiratory syncytial virus. J. clin. Microbiol., 24, 596-599 (1986).
21. WATERHOUSE, J., MUIR, C., SHANMUGARATHNAM, K. and POWEL, J., Cancer incidence in five continents, Vol. 5, IARC Sci. Publ. 42, IARC, Lyon (1982).
22. ZENG, Y., Seroepidemiological studies on nasopharyngeal carcinoma in China. Adv. Cancer Res., 44, 121-138 (1985).
23. ZENG, Y., ZHANG, L.G., LI, H.Y., JAN, M.G., ZHANG, Q., WU, Y.C. and SU, G.R., Serological mass survey for early detection of nasopharyngeal carcinoma in Wuzhou city, China. Int. J. Cancer, 29, 139-141 (1982).